[1]
Fukunaga, A. et al. 2018. Efficacy of Oral Ruxolitinib in a Patient with Refractory Chronic Spontaneous Urticaria. Acta Dermato-Venereologica. 98, 9 (Jul. 2018), 904–905. DOI:https://doi.org/10.2340/00015555-3006.